Literature DB >> 26549106

Phosphorylation of eIF2α Is a Translational Control Mechanism Regulating Muscle Stem Cell Quiescence and Self-Renewal.

Victoria Zismanov1, Victor Chichkov1, Veronica Colangelo2, Solène Jamet3, Shuo Wang3, Alasdair Syme4, Antonis E Koromilas4, Colin Crist5.   

Abstract

Regeneration of adult tissues depends on somatic stem cells that remain quiescent yet are primed to enter a differentiation program. The molecular pathways that prevent activation of these cells are not well understood. Using mouse skeletal muscle stem cells as a model, we show that a general repression of translation, mediated by the phosphorylation of translation initiation factor eIF2α at serine 51 (P-eIF2α), is required to maintain the quiescent state. Skeletal muscle stem cells unable to phosphorylate eIF2α exit quiescence, activate the myogenic program, and differentiate, but do not self-renew. P-eIF2α ensures in part the robust translational silencing of accumulating mRNAs that is needed to prevent the activation of muscle stem cells. Additionally, P-eIF2α-dependent translation of mRNAs regulated by upstream open reading frames (uORFs) contributes to the molecular signature of stemness. Pharmacological inhibition of eIF2α dephosphorylation enhances skeletal muscle stem cell self-renewal and regenerative capacity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26549106     DOI: 10.1016/j.stem.2015.09.020

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  85 in total

Review 1.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

2.  Single cell analysis of adult mouse skeletal muscle stem cells in homeostatic and regenerative conditions.

Authors:  Stefania Dell'Orso; Aster H Juan; Kyung-Dae Ko; Faiza Naz; Jelena Perovanovic; Gustavo Gutierrez-Cruz; Xuesong Feng; Vittorio Sartorelli
Journal:  Development       Date:  2019-04-11       Impact factor: 6.868

Review 3.  Towards stem cell therapies for skeletal muscle repair.

Authors:  Robert N Judson; Fabio M V Rossi
Journal:  NPJ Regen Med       Date:  2020-05-11

Review 4.  Translational Control during Developmental Transitions.

Authors:  Felipe Karam Teixeira; Ruth Lehmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-06-03       Impact factor: 10.005

5.  Tis11 mediated mRNA decay promotes the reacquisition of Drosophila intestinal stem cell quiescence.

Authors:  Lindy McClelland; Heinrich Jasper; Benoît Biteau
Journal:  Dev Biol       Date:  2017-04-23       Impact factor: 3.582

Review 6.  Stem Cell Quiescence: Dynamism, Restraint, and Cellular Idling.

Authors:  Cindy T J van Velthoven; Thomas A Rando
Journal:  Cell Stem Cell       Date:  2019-02-07       Impact factor: 24.633

7.  eIF2α, a potential target for stem cell-based therapies.

Authors:  Ryo Fujita; Yusuke Ono
Journal:  Stem Cell Investig       Date:  2016-07-22

Review 8.  Cellular Mechanisms and Regulation of Quiescence.

Authors:  Océane Marescal; Iain M Cheeseman
Journal:  Dev Cell       Date:  2020-11-09       Impact factor: 12.270

9.  Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential.

Authors:  Robert N Judson; Marco Quarta; Menno J Oudhoff; Hesham Soliman; Lin Yi; Chih Kai Chang; Gloria Loi; Ryan Vander Werff; Alissa Cait; Mark Hamer; Justin Blonigan; Patrick Paine; Linda T N Doan; Elena Groppa; WenJun He; Le Su; Regan H Zhang; Peter Xu; Christine Eisner; Marcela Low; Ingrid Barta; Coral-Ann B Lewis; Colby Zaph; Mohammad M Karimi; Thomas A Rando; Fabio M Rossi
Journal:  Cell Stem Cell       Date:  2018-01-25       Impact factor: 24.633

Review 10.  Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease.

Authors:  Albert E Almada; Amy J Wagers
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03-09       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.